Aubrey Capital Management’s Halozyme HALO Stock Holding History

Aubrey Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,199	Closed	-$641K	–	59
2024 Q3	$641K	Hold	11,199	–	–	0.25%	39
2024 Q2	$547K	Hold	11,199	–	–	0.22%	41
2024 Q1	$422K	Hold	11,199	–	–	0.15%	51
2023 Q4	$414K	Hold	11,199	–	–	0.18%	52
2023 Q3	$404K	Hold	11,199	–	–	0.23%	43
2023 Q2	$404K	Hold	11,199	–	–	0.27%	40
2023 Q1	$428K	Hold	11,199	–	–	0.25%	37
2022 Q4	$637K	Hold	11,199	–	–	0.51%	31
2022 Q3	$443K	Hold	11,199	–	–	0.38%	30
2022 Q2	$493K	Hold	11,199	–	–	0.4%	34
2022 Q1	$447K	Buy	11,199 +2,300	+26%	+$81.9K	0.26%	41
2021 Q4	$358K	Hold	8,899	–	–	0.14%	31
2021 Q3	$362K	Sell	8,899 -1,784	-17%	-$74.6K	0.11%	32
2021 Q2	$485K	Hold	10,683	–	–	0.14%	32
2021 Q1	$445K	Buy	10,683 +3,641	+52%	+$166K	0.13%	36
2020 Q4	$301K	Buy	+7,042	New	+$253K	0.08%	39

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aubrey Capital Management's HALO Position: Q4 2024 in Review

Aubrey Capital Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 11,199 shares — an estimated $641K sold.

Aubrey Capital Management first reported a position in HALO in Q4 2020 and held it in 16 quarters. The position peaked at $641K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

Aubrey Capital Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
Aubrey Capital Management sold 11,199 Halozyme shares in Q4 2024, an estimated $641K.
Aubrey Capital Management first reported a position in Halozyme in Q4 2020 and held it in 16 quarters.
Aubrey Capital Management's Halozyme position peaked at $641K in Q3 2024.
508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Aubrey Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.